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INTRODUCTION
Autoimmune progesterone dermatitis was first described by 
Géber
1 and is a rare disease caused by an autoimmune response 
to endogenous progesterone in women of child-bearing age. 
Skin lesions occur periodically during the luteal phase of the 
menstrual cycle due to increases in progesterone.
2,3 Patients 
with eczematous skin lesions are frequently misdiagnosed with 
eczematoid dermatitis or allergic contact dermatitis, leading to 
delays in treatment. We report a case of autoimmune proges-
terone dermatitis misdiagnosed as allergic contact dermatitis 
that had been treated without improvement.
CASE REPORT
A 48-year-old woman visited our clinic with a 6-year history of 
eczematous skin lesions on the pretibial areas, forearms, elbows, 
and buttocks bilaterally, with fluctuating clinical symptoms. She 
had been treated for allergic contact dermatitis without any im-
provement. There was no medical or family history of allergic 
disease. She had a 6-month history of oral contraceptive use in 
her 20s, but had not taken other medications since then. She 
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was twice admitted to hospital for aggravation of her skin lesions. 
On her last admission, skin biopsies revealed findings sugges-
tive of subacute eczematous dermatitis (Fig. 1A) and an inflam-
matory cell infiltrate, including eosinophils (Fig. 1B), which led 
to a diagnosis of allergic contact dermatitis without any identi-
fiable causes.
The physical examination revealed multiple eczematous le-
sions ranging from the size of a small coin to 12 × 8 cm (Fig. 2A). 
A complete blood cell count showed hemoglobin 9.8 g/dL, he-
matocrit 29.5%, white blood cells 7,890/µL (eosinophils 690/µL) 
and platelets 505,000/µL. Liver and thyroid function tests were 
within normal limits. Her progesterone level was 7.84 ng/mL 
(3.3–25.0 ng/mL) in the luteal phase.
Skin prick tests were negative for representative inhalant aller-
gens, and the serum total IgE level was 22.5 IU/mL. Since the 
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Autoimmune progesterone dermatitis is a rare autoimmune response to endogenous progesterone that usually occurs in fertile females. Cutaneous 
or mucosal lesions develop cyclically during the luteal phase of the menstrual cycle when progesterone levels are elevated. Symptoms usually start 
3–10 days before menstruation and resolve 1–2 days after menstruation ceases. We report the case of a 48-year-old woman with intermittent ec-
zematous skin lesions of the legs, forearms, and buttocks. She was diagnosed with allergic contact dermatitis, and topical steroids were prescribed. 
Her skin eruptions waxed and waned for 6 years and were associated with her menstrual cycle. We performed an intradermal test using progester-
one, which was positive, and prescribed gonadotropin-releasing hormone analogues monthly for 3 months. The patient’s skin lesions improved, con-
firming the diagnosis. Autoimmune progesterone dermatitis should be included in the differential diagnosis of recurrent eczema that is refractory to 
treatment in women of child-bearing age.
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aggravation of her skin lesions was associated with her men-
strual cycle, we performed an intradermal test using 50 mg/mL 
progesterone (Taiyu Progesterone
, Jaytech Biogen, Seoul, Ko-
rea) at dilutions of 1:10 and 1:1. Histamine was used as a posi-
tive control, and normal saline was used as a negative control. 
The immediate reaction was read 15 minutes after intradermal 
injection of the test solutions, and the late reaction was read at 
48 hours. The results revealed a positive immediate response 
(Fig. 3), but no late response. Since the patient was 48 years old 
and near menopause, she was given three doses of gonadotro-
pin-releasing hormone (GnRH) at 1-month intervals. Subse-
quently, she entered menopause, and her skin lesions resolved 
completely (Fig. 2B).
DISCUSSION
Since Géber
1 first described autoimmune progesterone der-
matitis in 1921, about 50 cases have been reported in the inter-
national literature. In the Korean literature, Hur and Chun
3 re-
ported one case of autoimmune progesterone dermatitis and 
Lee et al.
4 presented another case in which circulating autoanti-
body was identified.
The pathogenesis of autoimmune progesterone dermatitis re-
mains unclear.
5 It is proposed that after exposure to exogenous 
Fig. 1.  (A) The biopsy specimen from the left lower leg consisted of an ellipsoid skin sample with underlying subcutaneous tissue. The hematoxylin and eosin 
stained histologic section was consistent with acute to subacute eczematous dermatitis (H&E stain, ×40). (B) The histologic section shows an inflammatory cell infil-
tration around follicular and perivascular tissues with increased dermal eosinophils (H&E stain, ×200).
A B
Fig. 2.  (A) Fixed, nummular eczematous dermatitis was present on both lower legs. (B) The previously observed dermatitis improved after 3 months of GnRH ana-
logue treatment.
A BAutoimmune Progesterone Dermatitis AAIR 
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progesterones, especially oral contraceptives or intrauterine 
devices, sensitized presenting cells and T helper 2 lymphocytes 
generate specific IgE antibodies, which then cause skin lesions 
via type 1 hypersensitivity reaction as progesterone levels rise.
6 
This hypothesis is supported by findings of eosinophilia in the 
peripheral blood and dense perivascular eosinophilic infiltra-
tion around vessels on skin biopsy.
7 In our patient, the periph-
eral eosinophil count was elevated at 690/µL, and eosinophilic 
infiltration was observed on skin biopsy (Fig. 1B). Intradermal 
tests with progesterone show both immediate reactions (within 
30 minutes) and delayed reactions (24–48 hours later) and may 
indicate both types I and IV hypersensitivity reactions.
8 Only an 
immediate reaction was observed in our patient, although we 
did not perform a progesterone patch test to evaluate a type IV 
reaction. The presence of anti-progesterone antibodies sug-
gests other pathogenic mechanisms,
9 including type III hyper-
sensitivity reaction to antigen-antibody complexes that are de-
posited in the skin, which could induce dermatitis, as proges-
terone secretion increases before and after menstruation.
10 
Since this antibody is not detected in all patients, this hypothe-
sis only partially explains the pathogenesis.
11 We did not test for 
anti-progesterone antibodies in our case.
The typical clinical symptoms of autoimmune progesterone 
dermatitis are skin lesions that develop 3–10 days before men-
struation and persist up to 1–2 days after the end of the men-
strual cycle, with recurrent cyclic aggravation, closely related to 
the serum progesterone concentration.
12 In our patient, the skin 
lesions worsened 1 week before menstruation and improved 
2–3 days after the end of the menstrual cycle. The skin lesions 
were associated with urticaria, erythema multiforme, eczema, 
itching, and vesicular lesions.
2 Since eczematous skin lesions 
are frequently accompanied by itching and are chronic, with 
frequent recurrences despite medical treatment, they can be 
misdiagnosed as contact dermatitis, as in our case. In cases of 
allergic contact dermatitis, eczematous skin lesions occur on 
the face, neck, wrists, and flexural areas of the lower extremi-
ties, and the condition can be diagnosed with a patch test.
13
The diagnostic criteria for autoimmune progesterone derma-
titis proposed by Warin
14 are as follows: (1) skin lesions related 
to the menstrual cycle; (2) positive response to intradermal 
testing with progesterone; and (3) symptomatic improvement 
Fig. 3.  Intradermal testing with progesterone (1: 10, 1: 1) was positive after 15 
min.
after inhibiting progesterone secretion by suppressing ovula-
tion. In the intradermal test, immediate and late reactions may 
occur, so the reactions should be monitored for up to 24–48 
hours after allergen injection.
1,11
Autoimmune progesterone dermatitis is not very responsive 
to antihistamines and steroids.
15 Therefore, treatment modali-
ties that inhibit progesterone secretion by suppressing ovula-
tion are used widely. GnRH analogues and tamoxifen can suc-
cessfully treat this disease by suppressing menstruation, but 
tamoxifen may induce venous thromboembolism and cataract 
formation.
16 For cases that are refractory to medical treatment, 
bilateral oophorectomy can be considered definitive treat-
ment.
11,17
In conclusion, we report a case of autoimmune progesterone 
dermatitis that was initially diagnosed as allergic contact der-
matitis and treated without symptomatic improvement. The 
patient was diagnosed after a positive response to an intrader-
mal test with progesterone and was successfully treated with 
GnRH analogues. Autoimmune progesterone dermatitis should 
be included in the differential diagnosis of recurrent eczema 
that is refractory to treatment in women of child-bearing age.
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